Related Experiment Video
Updated: Jun 30, 2025

Near Infrared NIr Light Increases Expression of a Marker of Mitochondrial Function in the Mouse Vestibular Sensory Epithelium
Published on: March 14, 2015
Nocturnal vestibular stimulation using a rocking bed improves a severe sleep disorder in a patient with mitochondrial
Alexander Breuss1, Marco Strasser2, Jean-Marc Nuoffer3
1ETH Zurich, Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems, Zurich, Switzerland.
Insights
This case study shows that rocking beds may improve severe sleep disorders in children with mitochondrial disease. The intervention significantly increased sleep duration and reduced fatigue and caregiver needs.
Area of Science:
- Neurology
- Sleep Medicine
- Genetics
Background:
- Mitochondrial diseases are rare genetic disorders.
- Severe sleep disturbances are common in mitochondrial diseases.
- This case involves a 12-year-old boy with severe primary mitochondrial disease and disrupted sleep.
Observation:
- The patient's parents noted improved sleep during train rides.
- This observation led to the use of a rocking bed with multimodal sensory stimuli.
- Interventions mimicked sensory experiences of train travel.
Findings:
- Sleep duration increased by 25% during a 4-week rocking bed intervention.
- Caregiver interactions and time decreased by 75% and 40%, respectively.
- Subjective fatigue decreased by 40%, and daytime sleepiness and anxiety improved.
Implications:
- Rocking beds may offer a novel treatment for severe, persistent sleep disorders in specific patient groups.
- Further research is needed to validate these findings in larger populations.
- This approach could potentially benefit patients with sleep disorders and other conditions.
Abstract:
Mitochondrial diseases are rare genetic disorders often accompanied by severe sleep disorders. We present the case of a 12-year-old boy diagnosed with a severe primary mitochondrial disease, exhibiting ataxia, spasticity, progressive external ophthalmoplegia, cardiomyopathy and severely disrupted sleep, but no cognitive impairment. Interestingly, his parents reported improved sleep during night train rides. Based on this observation, we installed a rocking bed in the patient's bedroom and performed different interventions, including immersive multimodal vestibular, kinesthetic and auditory stimuli, reminiscent of the sensory experiences encountered during train rides. Over a 5-month period, we conducted four 2-week nocturnal interventions, separated by 1-week washout phases, to determine the subjectively best-perceived stimulation parameters, followed by a final 4-week intervention using the optimal parameters. We assessed sleep duration and quality using the Mini Sleep Questionnaire, monitored pulse rate changes and used videography to document nocturnal interactions between the patient and caregivers. Patient-reported outcome measures, clinical examinations and personal outcomes of specific interests were used to document daytime sleepiness, restlessness, anxiety, fatigue, cognitive performance and physical posture. In the final 4-week intervention, sleep duration increased by 25%, required caregiver interactions reduced by 75%, and caregiving time decreased by 40%. Subjective fatigue, assessed by the Checklist Individual Strength, decreased by 40%, falling below the threshold of severe fatigue. Our study suggests that rocking beds could provide a promising treatment regime for selected patients with persistent severe sleep disorders. Further research is required to validate these findings in larger patient populations with sleep disorders and other conditions.
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Equilibrium and Balance
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

